###begin article-title 0
Ets-2 and p53 mediate cAMP-induced MMP-2 expression, activity and trophoblast invasion
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
We have previously shown that Matrix metalloproteinase (MMP) -2 is a key-enzyme in early trophoblast invasion and that Protein Kinase A (PKA) increases MMP-2 expression and trophoblast invasion. The aim of this study was to examine MMP -2 regulation by PKA in invasive trophoblasts: JAR choriocarcinoma cell-line and 6-8 w first trimester trophoblasts.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
The effect of Forskolin (PKA) on MMP-2 expression was assessed by Northern Blot and RT-PCR. Possible transcription factors binding to consensus MMP-2 promoter sequences in response to Forskolin, were detected by EMSA binding assay and their expression assessed by western blot analysis. Antisense transfection of relevant transcription factors was performed and the inhibitory effect assessed on MMP-2 expression (RT-PCR), secretion (zymography) and trophoblast invasiveness (transwell migration assay).
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
We found that Forskolin increased MMP-2 mRNA in JAR cells within 24 hours, and induced binding to p53, Ets, C/EBP and AP-2. Transcription factors Ets-2, phospho- p53, C/EBP epsilon, C/EBP lambda and AP-2 alpha bound to their respective binding sequences in response to Forskolin and the expressions of these transcription factors were all elevated in Forskolin- treated cells. Inhibition of Ets-2 and p53 reduced MMP-2 expression, secretion and invasiveness of Forskolin treated cells.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
MMP-2 is regulated by PKA through several binding sites and transcription factors including Ets-2, p53, C/EBP, C/EBP lambda and AP-2 alpha. Ets-2 and p53 mediate cAMP- induced trophoblast invasiveness, through regulation of MMP-2.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
During implantation the trophoblast exhibit behavior similar to tumor cells, including tissue invasiveness, metastasis, loss of contact inhibition, escape from immune surveillance and massive proliferation ability [1]. However, in sharp contrast to aggressive tumors, trophoblast invasion process is a spatial and temporal strictly regulated process, controlled by multiple interactions between cells and environment, mediated by several factors including growth factors, hormones and cytokines [2,3].
###end p 10
###begin p 11
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 756 757 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
Trophoblast are highly invasive due to the secretion of extracellular proteases, like Matrix Metalloproteinases (MMPs), mediating degradation of the extracellular matrix (ECM), and of their balancing inhibitors Tissue inhibitors of Metalloproteinases (TIMPs) [4-6]. The two gelatinases, MMP-2 and MMP-9, digest type IV collagen, the main component of the basement membrane and are therefore regarded as key enzymes in trophoblast invasion [5,7-9]. MMP-2 and MMP-9 expression is differential during the first trimester of pregnancy. MMP-2 production is dominant until 8 weeks of gestation and then declining, whereas MMP-9 production significantly increases from 8 weeks, causing a shift of dominant gelatinase from MMP-2 to MMP-9 from 9 week of gestation [8,9]. The implantation process occurs by two waves of invasion by the trophoblast, the first strictly controlled to the implantation site and completed at 8 weeks of gestation, and the second wave deep into the uterine wall at the end of first trimester [10,11]. MMP-2 is likely to be the key-enzyme in the first physiological invasion wave, whereas MMP-9 may be the key-enzyme in the second invasion wave.
###end p 11
###begin p 12
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 976 979 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 1003 1004 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1103 1105 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1195 1197 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 541 546 <span type="species:ncbi:9606">human</span>
The JAR cell line, obtained from choriocarcinoma, is comprised of highly invasive trophoblast, expressing mainly MMP-2 and to a much lesser extent MMP-9 [8,12,13]. JAR cells were shown in our lab to resemble early 1st trimester trophoblast in gelatinase profile and invasiveness, and can therefore be used as a good model for studying early invasive trophoblast regulation [8]. Several factors with importance in embryo implantation act via cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) signal transduction pathway, including human chorion gonadotropin (hCG), the primary signal of an implanting pregnancy [14,15]. hCG was found to increase collagenolytic activity, trophoblast invasion and migration [15-17], and MMP-9 [18]. Forskolin is a prototypical stimulator of the cAMP pathway by direct activation of adenylate cyclase [19]. In a previous study, we showed that Forskolin (PKA) induces MMP-2 and MMP-9 and trophoblast invasiveness in both JAR cells and 1st trimester trophoblasts [8]. Forskolin has been used also in other studies to induce invasion or invasion-related molecules [19,20]. Additionally, Forskolin/cAMP has been used to induce syncytiotrophoblast formation [21,22]. The use of cell-lines of different origin as well as primary or term trophoblast may be the cause of these differential effects.
###end p 12
###begin p 13
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Most MMPs are regulated at the transcriptional level, by several cytokines and growth factors, which influence multiple signaling pathways [23]. The MMP gene promoter contains several cis-regulatory elements, often acting synergistically, with varying importance and effect, depending upon cell-type and inducer [6]. The MMP -2 promoter lacks a typical TATA-box, but is not refractory to modulations as previously thought [24,25]. The transcriptional regulation on MMP-2 in trophoblasts is not yet clear. The aim of this study was to investigate the transcriptional regulation of MMP-2 in cAMP- activated invasive trophoblast. Other MMP regulation levels include mRNA stabilization, protein activation or inhibition, surface localization and secretion; however these levels were not part of the present study.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Cell culture
###end title 15
###begin p 16
###xml 291 293 285 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 183 187 <span type="species:ncbi:9913">Calf</span>
The JAR (Jar, HTB 144, ATCC) human choriocarcinoma line was a generous gift from Pr. Hochberg, Hebrew University, Israel. JAR cells were cultured in M-199 medium containing 10% Fetal Calf Serum (FCS) and penicillin/streptomycin (all Beit-Ha'Emek, Israel) at 37degreesC in a humidified, 5% CO2 atmosphere. After 24 h, medium was changes to M-199 medium with 1.5% serum, in the presence or absence of Forskolin 10 muM (Sigma, ST Louis, MO, USA).
###end p 16
###begin title 17
###xml 29 34 <span type="species:ncbi:9606">human</span>
Isolation and cultivation of human cytotrophoblast
###end title 17
###begin p 18
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
Human trophoblast cells were obtained from legal abortions (6 to 8 weeks), with the approval of the local ethical committee (in compliance with the Helsinki Declaration) and the consent of the participating patients. Trophoblast cells were isolated according to a protocol generously provided by Desoye G, clinic of Obstetrics and Gynecology, Austria. Briefly, placenta were washed in saline, then the minced trophoblastic villi were digested by 0.25% trypsin and DNase I (both Sigma, ST Louis, MO, USA), and CTB separated from blood cells and decidua on a discontinuous Percoll gradient (Sigma, ST Louis, MO, USA). Contaminating
###end p 18
###begin p 19
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
leukocytes were removed by immunopurification with anti- CD45RB (DAKO, Glostrup, Denmark) coupled to magnetic particle. This method supplies a 95-98% purity of trophoblast, including all trophoblast sub-groups [26]. Cells were cultured in M-199 medium supplemented with 1.5% FCS and 1% penicillin/streptomycin for the various experiments.
###end p 19
###begin title 20
Substrate-gel-electrophoresis (zymography)
###end title 20
###begin p 21
###xml 494 495 488 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Proteolytic activity of culture supernatants were detected using gelatin-substrate gel electrophoresis (zymography). Samples, normalized to cell count performed with XTT Reagent kit (Beit-Ha'Emek, Israel), were diluted in sodium dodecyl sulphate (SDS) sample buffer and electrophoresed through a 10% SDS-polyacrylamid gel containing 0.5% gelatin. Afterwards, gels were rinsed in 2.5% Triton X-100 (Sigma, St. Louis, MO, USA) and incubated for 24 h at 37degreesC in 0.2 mol/l NaCl, 5 mmol/l CaCl2, 0.2% Brij 35 and 50 mmol/l Tris, pH 7.5. Gels were stained with Coomassie Blue G in 30% methanol and 10% acetic acid. Each gelatinase band was identified in accordance to the molecular weight and commercial standards (data not shown). Bands on each gel were compared to their control band and quantified with a densitometer system, endowed with Bio-Capt and TINA software (Raytest, Staubenhardt, Germany).
###end p 21
###begin title 22
Matrigel invasion assay
###end title 22
###begin p 23
###xml 178 180 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5 </sup>
###xml 404 405 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 607 613 <span type="species:ncbi:3635">cotton</span>
Matrigel (1 mg/ml) (BD Biosciences, Franklin Lakes, NJ, USA) diluted in serum free media was added to upper chamber of 24-well transwell plate (8 mum pores, Corning, MA, USA). 105 cells in 100 mul media were added to the upper chamber, and 500 mul media added to the lower chamber. 10 muM Forskolin was added to medium in upper and lower wells and cells incubated at 37degreesC for 48-72 hours. Cells (105/well) seeded simultaneously in the same media in a well without transwell, served as reference of total seeded cells. After incubation non-invaded cells on top of the transwell were scraped off with a cotton swab and the amount of invaded cells in the lower well as well as the amount of total seeded cells was evaluated with XTT Reagent kit. The percent of invasion was calculated as:
###end p 23
###begin p 24
Invasion was expressed as Invasion Index (Percent of control).
###end p 24
###begin title 25
RNA extraction
###end title 25
###begin p 26
Total cellular RNA was extracted using a total RNA isolation kit EZ-RNA (Beit HaEmek, Israel) according to manufacturer's instructions. RNA concentration was determined spectro-photo-metrically.
###end p 26
###begin title 27
Northern blot analysis
###end title 27
###begin p 28
15 mug of total RNA was electrophoresed on a 1% denaturating agarose gel and transferred to a nitrocellulose membrane. The membrane was hybridized with 2 mug/lane complimentary digoxigenin-labeled DNA probe for MMP-2 or GAPDH (Biognostik, Gottingen, Germany) using the digoxigenin (DIG) Easy Hyb system, according to manufacturer's instructions (Roche, Basel, Switzerland). The probes were previously labeled with digoxigenin by terminal transferase labeling kit (Roche, Basel, Switzerland). The membrane was then rinsed in 2x SSC/SDS and in 0.1x SSC/SDS. Bands were detected with anti-digoxigenin-AP antibody and the chemiluminescent substrate CSPD (both Roche, Basel, Switzerland) on X-ray film.
###end p 28
###begin title 29
Reverse transcription-polymerase chain reaction (RT-PCR)
###end title 29
###begin p 30
###xml 178 180 176 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 113 116 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
First-strand cDNA was synthesized from 2-4 mug of total RNA using 0.5 mug oligo (dt) primer, 1 mM dNTP, 15 Units AMV reverse transcriptase (Promega, Mannheim, Germany), 5 mM MgCl2 and buffer (10 mM Tris0Hcl, 50 mM KCL, o.1% Triton x-100). RT-PCR was performed in a final volume of 50 mul containing 10 mul cDNA, 10 mM dNTPs (Promega, Mannheim, Germany), 1.5 U Taq polymerase (Sigma, ST Louis, MO, USA), 50 pmol of each primer and 1x reaction buffer. Amplification parameters were 30 cycles as follows: denaturation, 30 sec at 94 degreesC, annealing, 60 sec at 58 degreesC, extension, 90 sec at 72 degreesC. MMP-2 primer forward (F): ACCTGGATGCCGTCGTGGAC and reverse (R): TGTGGCAGCACCAGGGCAGC, GAPDH primer F: TGAACGGGAAGCTCACTGG and R: TCCACCACCCTGTTGCTGTA (IDT Inc., Hy-Labs, Rehovot, Israel). Amplification of GAPDH gene transcripts was performed simultaneously to confirm RNA integrity, efficiency and for quantification of cDNA. Negative control reactions containing samples without cDNA or Taq enzyme were used (data not shown). RT-PCR products were analyzed by 2.5% agarose gel electrophoresis. Images were captured with Polaroid (Hertfordshire, UK) film under UV light. Products were quantified using a Densitometer system endowed with TINA software (Raytest, Staubenhardt, Germany).
###end p 30
###begin title 31
Preparation of nuclear extract
###end title 31
###begin p 32
###xml 14 17 14 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
JAR cells or 1st trimester trophoblasts were incubated in serum-free medium for 24 hours, with or without 10 muM Forskolin. Cells were lysed with swelling buffer (10 mM Hepes, 10 mM KCL, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 10 mug/mul Leupeptin, 50 mug/ml Aprotinin) for 15 min at 4degreesC, then 10% NP-40 was added for lysis and cells centrifuged at 4degreesC for 3 min at 3000 RPM. The cytosol protein extract was collected and the remaining pellet resuspended in extraction buffer (20 mM Hepes, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 10 mug/mul Leupeptin, 50 mug/ml Aprotinin), vortexed and kept at 4degreesC for 15 min, then centrifuged at 4degreesC for 5 min at 12000 RPM. The protein concentration was determined with Bradford reagent assay (Bio-Rad laboratories, Washington, DC). Nuclear extract was assayed for the presence of transcription factors, entering the nucleus in response to stimulus.
###end p 32
###begin title 33
Electrophoretic mobility shift assay
###end title 33
###begin p 34
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
Transcription factor activities were assessed by EMSA using double-stranded oligonucleotide corresponding to the consensus sequences of the MMP-2 promoter [25]. Oligonucleotides (Activator protein (AP)-1, AP-2, selective promoter factor (SP)-1, erythroblastosis virus E26 oncogene homolog (ETS), CCAAT-enhancer-binding protein (C/EBP), cAMP regulatory element binder (CREB), protein 53 (p53) [Santa Cruz Biotech, California, USA, (Table 1)] were labeled with digoxigenin (Roche, Basel, Switzerland) using Terminal Transferase according to manufacture's instructions in dig-labeling kit (Roche, Basel, Switzerland). Binding reactions were conducted by incubation of 6 mug of nuclear extract from JAR cells with digoxigenin- labeled oligonucleotide probes at 30degreesC for 30 min. in binding buffer containing 15 mM Hepes, 90 mM KCL, 6% glycerol, 3 mM DTT, 0.5 mug Poly [d(I-C)] and 0.4 ng oligonucleotide. Subsequently, DNA-protein complexes were separated from unbound oligonucleotides on a pre-electrophorized 6% polyacrylamide gel and electrotransferred to positively charged nylon membranes (Roche, Dyn Diagnostics Israel). The DNA-protein complexes were fixed by baking 30 min at 120degreesC. Bands were detected with anti-digoxigenin-AP antibody and the chemiluminescent substrate CSPD (both Roche, Basel, Switzerland) on X-ray film. Sequence specificity of nuclear protein-oligonucleotide interaction was confirmed by competition with cold oligonucleotide and by the addition of 100 mum PKA inhibitor H89 (Sigma, St. Louis, MO, USA) to the culture media. For supershift detection, 1 mul antibody (200 mug/0.1 ml) was added to nuclear extract mix and incubated for 30 min at 4degreesC before incubation with oligonucleotides, and a 4.5% polyacrylamide gel was used for separation. Antibodies used for supershift are listed under western blot.
###end p 34
###begin p 35
Commercial consensus oligonucleotide sequences (Santa Cruz)
###end p 35
###begin title 36
Western blot analysis
###end title 36
###begin p 37
###xml 499 510 <span type="species:ncbi:3704">horseradish</span>
###xml 783 786 <span type="species:ncbi:9860">Elk</span>
Equal amounts of nuclear (according to Bradford assay) and molecular mass marker were denatured and subjected to a 10% SDS-polyacrylamide gel electrophoresis. Proteins were electrotransferred to 0.45 mum nitrocellulose membranes (Scheicher & Schuel, Dassel, Germany). Non-specific binding was blocked overnight with 20% non-fat milk and Tris-buffered saline, containing 0.01% Tween-20. The membranes were incubated for 1 h with 1:2000 primary antibody, washed and incubated for 1 h with appropriate horseradish peroxidase-conjugated secondary antibody, then detected by chemiluminescence (ECL; Beit-Ha'Emek, Israel). The bands were quantified using a densitometer system endowed with BioCapt and TINA software (Raytest, Staubenhardt, Germany). Primary antibodies used: Ets-1, Ets-2, Elk-1, Net, PEA3, Erg 1/2/3, C/EBP alpha, C/EBP beta, C/EBP gamma, C/EBP lambda, C/EBP epsilon, p53, phospho-p53 (Ser 392 phosphorylated p53), AP-2alpha, Ap-2beta, AP-2gamma (Santa Cruz, Biotech, California, USA).
###end p 37
###begin title 38
Transient transfection of antisense against Ets-2 or p53
###end title 38
###begin p 39
###xml 17 19 17 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5 </sup>
JAR cells (5 x 105 per well) were plated on 24-well plates and transfected in duplicates with 750 nmol/liter antisense against humanEts2 (5'-/FAM/TTC CTT CCC ACC CTC CTA CC-3') or p53 (5'-/FAM/TCC GTC CCA GTA GAT TAC CAC-3) (IDT Inc., Hy-labs, Israel) in Optimem medium (Gibco, Invitrogen, Dorset, UK) using Lipofectamine (Invitrogen, Dorset, UK), according to manufacturer's protocol. After 6 hours, media with 20% serum was added to transfection media. After 24 hours post-transfection, cells were incubated in 10% FCS for 6 h and then plated for the various experiments. A reduction of at least 50% in Ets-2 or p53 distribution was considered a successful transfection.
###end p 39
###begin title 40
Immuno-fluorescence staining
###end title 40
###begin p 41
###xml 14 17 14 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 757 761 <span type="species:ncbi:9925">goat</span>
###xml 767 773 <span type="species:ncbi:9986">rabbit</span>
###xml 821 825 <span type="species:ncbi:9925">goat</span>
###xml 831 836 <span type="species:ncbi:10090">mouse</span>
JAR cells or 1st trimester trophoblasts were cultured on glass coverslips in 35 mul medium drops under mineral oil. Cells were washed with PBS and fixed with 3.7% Paraformaldehyde (Electron Microscope Sciences, Belgar) in PBS for 10 minutes at 4degreesC, then washed twice with PBS and permeabilized for 5 minutes at 4degreesC with 0.1% Triton (Sigma, St. Louis, MO, USA) in PBS. Slides were incubated for 1 hour with blocking buffer 3% BSA-PBS), washed 3 times with PBS and incubated for 30 minutes at room temperature with 1 mug primary antibodies (Anti MMP-2, Anti Ets-2, Anti p53). Slides were rinsed five times with PBS, then incubated for 30 minutes with 0.5 mug secondary antibody (for F-actin:phalloidin, AlexaFlour-488, A-12379; for Ets-2 and p53: goat anti-rabbit IgG conjugated with AlexaFlour-546; for MMP-2: goat-anti mouse IgG conjugated with AlexaFlour-633, all from Molecular Probes, Invitrogen, Dorset, UK). Stained cells were photographed using a confocal microscope (Bio-Rad radiance 2000 confocal set-up with a fluorescent microscope Nikon E600 with a 60x lens). The photos were analyzed by Image Pro software (Media Cybernetics, Bethesda, USA), which quantifies density per area.
###end p 41
###begin title 42
Statistical methods
###end title 42
###begin p 43
All data are expressed as mean +/- SEM. Statistical analysis of the data was performed using Student's t-test. P < 0.05 was considered significant.
###end p 43
###begin title 44
Results
###end title 44
###begin title 45
The effect of forskolin on MMP-2 expression in JAR and 6-8 w trophoblast
###end title 45
###begin p 46
###xml 252 255 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 579 581 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 611 613 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 725 727 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C</xref>
In order to explore the effect of Forskolin upon MMP-2 expression in JAR cells both Northern blot and RT-PCR was performed using the same RNA samples. In order to compare the results of the cell-line with primary cells RT-PCR was performed with 6-8 w 1st trimester trophoblast. Forskolin was added to JAR or 6-8 w trophoblast culture for various length of time, in order to find the optimal exposure. Figure 1 summarizes the results. The mRNA of MMP-2 was increased in JAR cells by Forskolin (10 muM), reaching a maximum after 24 hours of incubation (382% +/- 60, P = 0.02, Fig. 1A, 363% +/- 90, P = 0.03, Fig. 1B). In 6-8 w trophoblast a maximum was reached within 1 hour after adding Forskolin (147% +/- 17, P = 0.03, Fig. 1C). These exposures were chosen for further studies as optimal exposure for MMP-2 induction.
###end p 46
###begin p 47
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of forskolin on MMP-2 expression in JAR and 6-8 w trophoblast</bold>
###xml 70 79 70 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top panel</italic>
###xml 119 122 119 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A+B</bold>
###xml 146 147 146 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 237 238 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 288 292 287 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B+C)</bold>
###xml 294 306 293 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bottom panel</italic>
Effect of forskolin on MMP-2 expression in JAR and 6-8 w trophoblast. Top panel, total RNA of MMP-2 isolated form JAR (A+B) or 6-8 w trophoblast (C) cultured with Forskolin (10 muM) for the indicated times was assessed by Northern blot (A) and semiquantitative reverse transcription-PCR (B+C). Bottom panel, band intensities were quantified with Densitometer system endowed with TINA software and the data presented as the ratio of MMP-2 to GAPDH (percent of control). The value represents the mean +/- SEM from six different experiments performed in duplicates.
###end p 47
###begin title 48
Effect of forskolin on JAR nuclear protein binding to oligonucleotides sequences resembling binding sites found in the MMP-2 promoter
###end title 48
###begin p 49
###xml 314 315 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 521 523 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 524 526 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 536 537 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 642 644 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 708 709 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sub>
###xml 1141 1143 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
In order to detect transcription factors possibly involved in cAMP induction of MMP-2 in trophoblasts, we performed Gelshift assay (EMSA) of nuclear extract obtained from cells cultured for 24 hours in the presence or absence of 10 muM Forskolin. The binding of nuclear proteins to labeled oligonucleotides (Table 1), with sequences resembling binding sites found in the MMP-2 promoter, was explored. This method has been commonly used to detect possible binding sites and factors involved in transcriptional regulation [27-29]; Figure 2 summarizes the results. Forskolin increased binding to ETS, C/EBP, AP-2 and p53 DNA binding sites (Fig. 2A). No increase was found in binding to oligonucleotides SP-1, NFkB, AP-1 and CREB (data not shown). In order to assure binding specificity, competing non-labeled 8x excess oligonucleotide was added to reaction mixture. The non-labeled excess oligonucleotide strongly reduced the gelshift band, hereby ensuring binding specificity. Additionally, in order to assure involvement of the PKA signaling pathway, specific PKA inhibitor H89 (100 mum) was added to cell culture and gelshift performed (Fig 2B). H89 reduced binding activity and thereby confirmed the involvement of the PKA pathway (lane 3, 6, 9, 12).
###end p 49
###begin p 50
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of forskolin on JAR nuclear protein binding to oligonucleotides corresponding to MMP-2 promoter binding sites</bold>
###xml 118 119 118 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 538 539 537 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 816 817 814 815 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1104 1112 1101 1109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lane 1-2</bold>
###xml 1170 1178 1167 1175 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lane 3-4</bold>
###xml 1208 1216 1205 1213 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lane 5-6</bold>
###xml 1250 1258 1243 1251 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lane 7-8</bold>
###xml 1297 1308 1285 1296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lane 9-10, </bold>
Effect of forskolin on JAR nuclear protein binding to oligonucleotides corresponding to MMP-2 promoter binding sites. A, binding of nuclear proteins, extracted from JAR cells cultured with or without Forskolin (10 muM), to dig-labeled oligonucleotides corresponding to consensus binding sites in the MMP-2 promoter was assessed with EMSA. The specificity of the DNA-protein complexes was tested by competing with a 8-fold excess unlabeled probe (lane 4, 8, 12, 16) The pictures are representative results of twelve different experiments. B, binding of nuclear proteins extracted from JAR cells treated with or without Forskolin (10 muM) and in the presence or absence of PKA inhibitor H89 to dig-labeled oligonucleotides was assessed with EMSA. The pictures are representative results of five different experiments. C, Specific antibodies against relevant transcription factors were added to the reaction mixture and EMSA supershift assay performed to detect transcription factors binding to the complex of dig-labeled oligonucleotides and nuclear proteins from JAR cells cultured with 10 muM Forskolin. Lane 1-2, addition of phosho-p53 (pp53) antibody to cell extract. Lane 3-4, Addition of Ets-2 antibody. Lane 5-6, Addition of Ap-2alpha antibody. Lane 7-8, Addition of C/EBPlambda antibody and lane 9-10, addition of C/EBPepsilon antibody to cells treated with Forskolin. Supershifted bands are designated with an asterisk (*). This result is representative of seven different experiments.
###end p 50
###begin title 51
Identification of transcription factors binding to oligonucleotides involved in forskolin- induced MMP-2 expression
###end title 51
###begin p 52
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2C</xref>
###xml 802 805 <span type="species:ncbi:9860">Elk</span>
In order to explore transcription factors involved in Forskolin-induced MMP-2 expression, supershift EMSA was performed. In this assay, antibodies that recognize and identify the specific protein, bind to the protein-oligonucleotide complex, resulting in a higher, heavier band. Specific antibodies belonging to the families of transcription factors capable of binding to the relevant oligonucleotides were added to nuclear extract, prior to the binding reaction with oligonucleotides. Figure 2C shows the results. Antibodies to phospho- p53 (lane 2), to Ets-2 (lane 4), to Ap-2alpha (lane 6) and to C/EBPlambda (lane 8) and C/EBPepsilon (lane 10) supershifted the EMSA complex in Forskolin-treated cells. No supershift was found with other members of the various transcription factor families: ETS-1, Elk-1, Net, PEA3, Erg 1/2/3 (ETS); C/EBPalpha, c/EBPbeta, C/EBPgamma (C/EBP); p53 (p53); AP-2beta, AP-2gamma (AP-2) (data not shown).
###end p 52
###begin title 53
Detection of transcription factors induced by forskolin and possibly involved in MMP-2 regulation
###end title 53
###begin p 54
###xml 601 602 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 715 717 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 768 770 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 820 822 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 872 874 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
###xml 920 922 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3D</xref>
EMSA can only show which transcription factors perform increased binding to their respective binding sequence under stimulation of Forskolin but not whether these factors indeed bind to the MMP-2 promoter. In order to further verify our results we performed a complementary study, using western blot to detect transcription factors increased in the nucleus by Forskolin. Nuclear cell extract was prepared from JAR cells cultured 24 hours in the presence or absence of 10 muM Forskolin and western blot performed with antibodies against the same transcription factors previous tested with EMSA. Figure 3 shows the results. Forskolin increased significantly nuclear expression of AP-2 by 123% +/- 11, P = 0.043 (Fig. 3A), of C/EBPepsilon by 150% +/- 24, P = 0.049 (Fig. 4B), of C/EBPlambda by 159% +/- 22, P = 0.007 (Fig. 3B), of phospho-p53 by 169% +/- 34, P = 0.021 (Fig. 3C) and of Ets-2 by 151% +/- 22, P = 0.03 (Fig. 3D).
###end p 54
###begin p 55
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Detection of transcription factors induced by forskolin in JAR cells</bold>
###xml 527 537 524 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top panel </italic>
###xml 568 581 565 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bottom panel </italic>
###xml 784 785 781 782 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 800 801 797 798 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 817 818 814 815 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 832 833 829 830 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Detection of transcription factors induced by forskolin in JAR cells. The expression of various members of transcription factor families, capable of binding to AP-2, p53, C/EBP and ETS binding sites, found in the MMP-2 promoter, was examined with western blot. JAR cells were cultured in the absence or presence of 10 muM Forskolin and total nuclear proteins extracted. Band intensities were quantified with Densitometer system endowed with TINA software and the data represents the mean +/- SEM from 10 different experiments. Top panel shows representative pictures. Bottom panel - graphs showing quantification of bands. The control band intensity was indicated as 100 percent and is represented by black square. Gray square represents nuclear extract from Forskolin treated cells. A, AP-2 family; B, C/EBP family; C, p53 family; D, Ets family.
###end p 55
###begin p 56
###xml 350 352 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 353 355 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
Of the 5 different transcription factors Ets-2, phospho-p53, Ap-2alpha, C/EBPepsilon and C/EBPgamma, shown to be increased by Forskolin, Ets-2 and p53 were chosen for further study of their contribution to MMP-2 transcriptional regulation in trophoblasts. Both Ets-2 and p53 have previously been suggested to be involved in the implantation process [30-34].
###end p 56
###begin title 57
Involvement of Ets-2 in forskolin- induced MMP-2 expression and trophoblast invasiveness
###end title 57
###begin p 58
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A-F</xref>
###xml 747 755 743 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A, B, C</xref>
In order to further examine the involvement of Ets-2 in Forskolin- induced MMP-2 transcriptional regulation, we performed a silencing study using antisense against Ets-2. Ets-2 was inhibited by transfection of JAR cells with a specific antisense against Ets-2. Cells were then cultured in the absence or presence of Forskolin and four different parameters were analyzed. Figure 4A-F shows the results. Fluorescent antibody staining against Ets-2 and western blot analysis confirmed the inhibitory effect of the antisense. The transient transfection with Ets-2 antisense caused a 49% decrease in Ets-2 expression in non treated cells (100% vs.51% +/- 8, P < 0.05), and a 65% decrease in Forskolin-treated cells (139% vs. 74% +/- 6, P < 0.05) (Fig. 4A, B, C).
###end p 58
###begin p 59
###xml 0 119 0 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inhibitory effect of Ets-2 antisense upon forskolin-induced MMP-2 expression and secretion and trophoblast invasiveness</bold>
###xml 121 122 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 363 364 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 425 426 424 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 522 526 521 525 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-C </bold>
###xml 593 594 592 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 685 686 684 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 729 730 728 729 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 732 741 731 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top panel</italic>
###xml 929 930 928 929 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 932 944 931 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bottom panel</italic>
###xml 1154 1155 1151 1152 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1230 1232 1227 1229 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E </bold>
###xml 1232 1236 1229 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top </italic>
###xml 1275 1276 1272 1273 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1278 1290 1275 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bottom panel</italic>
###xml 1443 1444 1438 1439 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
Inhibitory effect of Ets-2 antisense upon forskolin-induced MMP-2 expression and secretion and trophoblast invasiveness. A, JAR cells were transfected with antisense against Ets-2 (As Ets-2), then cultured in the presence or absence of 10 muM Forskolin, simultaneously with non-transfected cells, then fixed and stained with a fluorescent antibody against Ets-2 (A), or nuclear proteins extracted and western blot performed (C). The results are representative photos taking with a confocal microscope, magnification x 60. A-C Results represent 3 different experiments performed in duplicates. B, Density of ETS-2 staining was quantified with Image software and presented by Bar graph. C, representative pictures of western blot. D, Top panel, Total RNA of MMP-2 from JAR cell, with or without treatment with Ets-2 antisense and in the presence or absence of Forskolin was assessed by semi-quantitative reverse transcription-PCR. D, Bottom panel, band intensities were quantified with Densitometer system and presented as ratio of MMP-2 to GAPDH, as percent of control. Data represents mean +/- SEM from 3 independent experiments performed in quadruples. E, MMP-2 secretion (72 kD) was assessed by zymography of conditioned media. E Top panel: Representative zymography gels. E, Bottom panel, Bar graph, representing mean +/- SEM from 3 independent experiments performed in quadruplets. The control band intensity was indicated as 100 percent. F, Bar graph representing cell invasion ability of transfected and non-transfected JAR cells tested with Transwell Invasion Assay from 4 different experiments performed in duplicates.
###end p 59
###begin p 60
###xml 164 166 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4D</xref>
###xml 371 373 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4E</xref>
###xml 559 561 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4F</xref>
The inhibition of Ets-2 did not significantly affect the Forskolin-induced expression of MMP-2 as assessed by RT-PCR (216% vs.200% +/- 10, not significantly) (Fig. 4D). However, a significantly 47% decrease in MMP-2 secretion in transfected cells, compared with non-transfected cells, both Forskolin-treated, was found by zymography (166% vs. 119% +/- 9, P < 0.05) (Fig. 4E). In addition Ets-2 inhibition caused a 52% decrease in trophoblast invasiveness, compared with non-transfected cells, both cultured with Forskolin (144% vs. 92% +/- 6, P < 0.05) (Fig. 4F).
###end p 60
###begin title 61
Involvement of p53 in forskolin- induced MMP-2 expression and trophoblast invasiveness
###end title 61
###begin p 62
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 388 393 384 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A, C</xref>
###xml 596 601 590 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5B, C</xref>
###xml 678 680 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5E</xref>
###xml 975 980 963 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5E, C</xref>
###xml 1181 1183 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5F</xref>
###xml 1515 1517 1497 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5G</xref>
JAR cell were transfected with specific antisense against p53, cultured in the presence or absence of Forskolin and experiments of four parameters performed. Figure 5 shows the result. The transient transfection with p53 antisense decreased p53 expression by 48% in control cells (100% vs. 52% +/- 11, P < 0.05) and by 85% in Forskolin-treated cells (150% vs. 65% +/- 18, P < 0.05) (Fig. 5A, C). The inhibition of p53 decreased the Forskolin-induced expression of MMP-2 by 85%, compared to non-transfected cells, as assessed with immunofluorescent staining (273% vs. 103% +/- 37, P < 0.05) (Fig. 5B, C) and by 146% as assessed with RT-PCR (283% vs. 137% +/- 21, P < 0.05) (Fig. 5E). This result shows that p53 transcription factor is involved in MMP-2 transregulation by Forskolin. p53 inhibition also reduced MMP-2 expression in control cells without Forskolin by 29% (RT-PCR) (100% vs. 71% +/- 10, P < 0.05) or by 47% (immunostaining) (100% vs. 53% +/- 15, P < 0.05) (Fig. 5E, C). This indicates that the p53 transcription factor is also involved in the constitutive expression of MMP-2. A correspondingly decrease in MMP-2 secretion was found by zymography in both groups (Fig. 5F): a 69% decrease in the presence of Forskolin (171% vs. 102 +/- 23, P < 0.05) and a 18% decrease without Forskolin (100% vs. 82% +/- 9, P < 0.05). In addition, p53 inhibition caused a 61% decrease in trophoblast invasiveness, compared with non-transfected cells, both cultured with Forskolin (190% vs. 129% +/- 12, P < 0.05) (Fig. 5G).
###end p 62
###begin p 63
###xml 0 117 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inhibitory effect of p53 antisense upon forskolin-induced MMP-2 expression and secretion and trophoblast invasiveness</bold>
###xml 279 280 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 281 282 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 448 449 447 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 469 470 468 469 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 531 532 530 531 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 535 539 534 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-D </bold>
###xml 606 609 605 608 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C, </bold>
###xml 728 731 727 730 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D, </bold>
###xml 771 772 770 771 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 772 781 771 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top panel</italic>
###xml 965 966 964 965 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 968 980 967 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bottom panel</italic>
###xml 1190 1191 1187 1188 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1266 1267 1263 1264 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1269 1273 1266 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top </italic>
###xml 1312 1313 1309 1310 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1315 1327 1312 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bottom panel</italic>
###xml 1480 1481 1475 1476 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
Inhibitory effect of p53 antisense upon forskolin-induced MMP-2 expression and secretion and trophoblast invasiveness. JAR cells were transfected with antisense against p53, then cultured in the presence or absence of 10 muM Forskolin, simultaneously with non-transfected cells. A,B, Representative photos taking with a confocal microscope of JAR cells, magnification x 60. JAR cells were fixed and stained with a fluoroscent antibody against p53 (A) or against MMP-2 (B), or nuclear proteins extracted and western blot performed (D). A-D Results represent 3 different experiments performed in duplicates. C, Density of p53 and MMP-2 staining was quantified with Image software and presented by Bar graph, black-p53, grey-MMP-2.D, representative pictures of western blot.ETop panel, Total RNA of MMP-2 from JAR cell, with or without treatment with Ets-2 antisense and in the presence or absence of Forskolin was assessed by semiquantative reverse transcription-PCR.E, Bottom panel, band intensities were quantified with Densitometer system and presented as ratio of MMP-2 to GAPDH, as percent of control. Data represents mean +/- SEM from 4 independent experiments performed in duplicates. F, MMP-2 secretion (72 kD) was assessed by zymography of conditioned media. F, Top panel: Representative zymography gels. F, Bottom panel, Bar graph, representing mean +/- SEM from 3 independent experiments performed in quadruplets. The control band intensity was indicated as 100 percent. G, Bar graph representing cell invasion ability of transfected and non-transfected JAR cells tested with Transwell Invasion Assay from 3 different experiments performed in quadruplets.
###end p 63
###begin title 64
The effect of forskolin on Ets-2 and p53 in 6-8 w 1st trimester trophoblasts - verification of similarity with cell-line results
###end title 64
###begin p 65
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 362 365 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 641 642 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 793 798 786 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6A, B</xref>
###xml 874 877 867 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 944 946 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6C</xref>
###xml 994 997 987 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
Trophoblast cell-lines are excellent models for studying the mechanism of implantation, but results should always be verified with primary cells. We therefore performed EMSA and immunofluorescent staining of Forskolin-treated 6-8 w 1st trimester trophoblastic cells in order to verify the presence and involvement of Ets-2 and p53 in these primary cells. 6-8 w 1st trimester trophoblast were cultured in the presence or absence of 10 muM Forskolin, then cells were fixed and stained with fluorescent antibodies against Ets-2, p53 and MMP-2, or total nuclear protein was extracted and EMSA performed with oligonucleotides Ets and p53. Figure 6 summarizes the results. Forskolin increased Ets-2, p53 and MMP-2 expression significantly by 164 +/- 7, 125 +/- 12 and 162 +/- 13, respectively (Fig. 6A, B), and increased binding activity to oligonucleotides p53 and Ets in 6-8 w 1st trimester trophoblasts, like previously found with JAR cells (Fig. 6C). This confirms the resemblance between 6-8 w 1st trimester trophoblast and JAR cells and indicates that the results obtained with JAR cell-line may be assumed to apply to early trophoblast with regards of gelatinolytic activity, regulation and invasiveness.
###end p 65
###begin p 66
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The effect of forskolin on Ets-2 and p53 expression in 6-8 w 1<sup>st </sup>trimester trophoblasts</bold>
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 211 214 211 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 362 363 361 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 469 473 468 472 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</bold>
###xml 481 487 480 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">middle</bold>
###xml 493 498 492 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</bold>
###xml 506 509 505 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C, </bold>
###xml 559 562 558 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
The effect of forskolin on Ets-2 and p53 expression in 6-8 w 1st trimester trophoblasts. A, Representative photos taking with a confocal microscope of 6-8 w 1st trimester trophoblast, magnification x 60. 6-8 w 1st trimester trophoblast, cultured with or without Forskolin (10 muM), were fixed and stained with a fluorescent antibody against Ets-2, p53 or MMP-2. B, Density of p53, Ets-2 and MMP-2 staining was quantified with Image software and presented by Bar graph, left-Ets-2, middle-p53, right-MMP-2. C, Binding of nuclear proteins extracted from 6-8 w 1st trimester trophoblast cells treated with or without Forskolin (10 muM) to dig-labeled oligonucleotides Ets and p53 was assessed with EMSA. Results represent 2 different experiments performed in triplicates.
###end p 66
###begin title 67
Discussion
###end title 67
###begin p 68
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1200 1203 1200 1203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 1410 1411 1410 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
We have found that Forskolin increases both trophoblast MMP-2 activity and MMP-2 mRNA expression. The maximal mRNA response in JAR cells appeared only after 24 hours of incubation, suggesting that Forskolin may stimulate MMP-2 by inducing other, early response genes. The MMP-9 gene has similarly been reported to be induced within 24 h in trophoblasts by 12-O-tetradecanoyl phorbol 13-acetate (TPA) and TNF, through transcription of early response genes [29]. In 6-8 w trophoblasts, in contrast, Forskolin induced MMP-2 mRNA within 1 h, indicating that Forskolin apparently can stimulate MMP-2 expression more directly, probably through initiating phosphorylation and migration of already present transcription factors. The controversy found here between JAR cells and 6-8 w trophoblasts, in regards of time for maximal mRNA response to Forskolin, underlines that some differences are to be expected between primary cells and a cell-line. One can speculate that in choriocarcinoma cells like JAR, an altered presence of transcription factors or activation of phosphorylation cascades may be part of the malignancy of these cells. The difference observed in ultimate magnitude between JAR cells and 1st trimester trophoblasts in response to Forskolin is consistent with our previous findings, showing the invasive choriocarcinoma cell-line to be highly expressing MMP-2, both in response to Forskolin and EGF [8]. The primary trophoblast are less invasive and express less MMP-2 than the JAR cells.
###end p 68
###begin p 69
Forskolin increased the binding of nuclear proteins to oligonucleotides corresponding to the consensus sequence of AP-2, C/EBP, p53 and Ets response elements in the MMP-2 promoter. These binding activities were induced specifically through PKA, since specific PKA- inhibitor H89 reduced this effect. The supershift EMSA assay revealed, that transcription factors AP-2alpha, phospho- p53, Ets-2 and C/EBPepsilon and -lambda bind to their respective binding sequence under stimulation of Forskolin. Forskolin also increased the protein expression of Ets-2, C/EBPepsilon, C/EBPlambda and AP-2alpha, and the phosphorylation of p53 as shown by western blot. These transcription factors may therefore be involved in transregulation of the MMP-2 promoter by Forskolin.
###end p 69
###begin p 70
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
Several transcription factors have been found to be involved in MMP-2 regulation in various cells, including AP-2, AP-1 and p53 [28,35,36]. Only a few studies of MMP-2 transcriptional regulation in trophoblast have been published, and have focused mainly on the signaling pathway involved. In 1st trimester trophoblast the MAPK/Erk1/2 pathway was found to be involved in induction of MMP-2 and MMP-9 by Cyclosporin A [37]. A cytoplasmatic tyrosine kinase named focal adhesion kinase was found to be involved in cell differentiation, adhesion, proliferation and MMP-2 activity in early trophoblast [38]. In another study from our lab, progesterone was found to regulate MMP-2 through differences in progesterone-receptor isoforms, apparently by binding to co-activators or transcription factors, since there is no progesterone response element in the MMP-2 promoter [39]. hCG, which like Forskolin acts through PKA, induces MMP-2 expression and trophoblast invasion through ERK 1/2 and PI3K/AKT pathways [40]. Our study is the first to focus on transcription factors, which mediate MMP-2 transcriptional regulation in trophoblasts. We chose to focus our further investigation upon two transcription factors, Ets-2 and p53, which have previously been suggested to be involved in the implantation process. We showed that that Ets-2 mediates Forskolin-induced MMP-2 activity, since Forskolin increased Ets-2 expression in trophoblast and since antisense inhibition of Ets-2 reduced the Forskolin-induced MMP-2 gelatinolytic activity and trophoblast invasion. Inhibition of Ets-2 did not significantly reduce MMP-2 transcription, indicating that this transcription factor alone, although essential to MMP-2 activity and function, is not sufficient to MMP-2 transcriptional regulation. Based on our results we hypothesize that Ets-2 may effect MMP-2 regulation on a post-transcriptional level, however further investigation is necessary to elucidate the exact mechanism.
###end p 70
###begin p 71
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 550 551 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sub>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 1250 1252 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1443 1445 1443 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1446 1448 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1767 1769 1767 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1978 1980 1978 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 2154 2156 2147 2149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 2157 2159 2150 2152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 2259 2261 2252 2254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 2262 2264 2255 2257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1115 1120 <span type="species:ncbi:10090">mouse</span>
###xml 1160 1164 <span type="species:ncbi:10090">mice</span>
###xml 1205 1210 <span type="species:ncbi:10090">mouse</span>
###xml 1890 1895 <span type="species:ncbi:9606">human</span>
The ETS transcription factor family is characterized by an highly evolutionary- conserved DNA- binding domain, that binds to a purine- rich GGA(A/T) core sequence [41,42]. Ets members direct cytoplasmic signals to control gene expression and mediate multiple signaling pathways such as the Ras- Map Kinases, Erk1,2, p38, JNK and the PI3 kinases, which control their activity, protein partnership and specification of downstream target genes [41-43]. Ets members have been shown to interact with several transcription factors including AP-1, pit-1, NFkB and SP-1 [34,42,44]. Ets proteins play important roles in cell development, differentiation and proliferation, and participate in malignancy of tumor cells, including invasion and metastasis, by activating the transcription of several cancer-related genes such as proteases and angiogenesis-related genes [41]. Binding sites for the ETS family are found in promoters of the MMP family [45], and regulation of matrix degrading proteases by Ets factors in tumor invasion and metastasis is well established [46]. Ets-2 is expressed in many cell types in developing mouse embryos. Targeted deletion of Ets-2 in mice results in retardation and death of the mouse embryo before 8.5 days of development [34]. These embryos show defects in the extraembryonic tissue gene expression and function, including deficient expression of MMP-9, MMP-13 and MMP-3 and die as a result of trophoblast failure [34,47]. Apparently. Ets-2 is not essential for specifying trophoectoderm before the morula-blastocyst transition, since blastocyst do form and initiate implantation. Properly Ets-2 coordinates early expression of genes providing full characteristics to cytotrophoblast, including the production of key enzymes and hormones [47]. MMP-2 may be one of these genes. Ets proteins mediate the control of several genes characteristically up-regulated in human trophoblast and involved in trophoblast differentiation and placenta development [32]. This includes the hCG-alpha and hCG-beta subunit gene, placental lactogen II, p-450 side chain cleavage enzyme, decidual/trophoblast prolactin related gene and MMP-1, -3 [48-51]. The hCG subunits are activated in stimulation to cAMP through interactions between Ets and CREB [32,47].
###end p 71
###begin p 72
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
We also found that Forskolin increases p53 expression, and that p53 mediates Forskolin-induced MMP-2 expression, gelatinolytic activity and both basic and PKA-induced trophoblast invasion. In contrast to Ets-2, transient transfection of antisense mRNA to p53 into trophoblasts decreased MMP-2 transcription, both in control and in Forskolin-treated cells. This indicates, that p53 may be involved in the constitutive expression of MMP-2, and additionally mediates the response to PKA. We have recently published that p53 is involved in MMP-2 regulation and trophoblast invasion by EGF [52]. p53 was among the transcription factors increased under EGF stimulation (p53, SP-1, AP-2alpha and -gamma, C/EBPepsilon and-lambda). p53 antisense inhibition was found to decrease EGF- induced MMP-2 mRNA expression, secretion and trophoblast invasiveness. Together our two studies emphasize the conclusion that p53 is involved in MMP-2 regulation in trophoblast. Since AP-2alpha and C/EBPepsilon and -lambda were also increased by both stimulators, they should be further examined by functional assays. Other transcription factors, like ETS-2, may be specific for a certain pathway.
###end p 72
###begin p 73
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 954 956 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 1104 1106 1104 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 1362 1364 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1465 1467 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1572 1574 1572 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1575 1577 1575 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 1578 1580 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 1708 1710 1708 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 1889 1891 1889 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1892 1894 1892 1894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1955 1957 1955 1957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 1991 1993 1991 1993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 2094 2096 2094 2096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 2097 2099 2097 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 2128 2130 2128 2130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 2179 2181 2179 2181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 2465 2467 2465 2467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 2664 2666 2664 2666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 2667 2669 2667 2669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B75">75</xref>
###xml 2829 2831 2829 2831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B76">76</xref>
###xml 3280 3283 3280 3283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st </sup>
###xml 879 884 <span type="species:ncbi:9606">human</span>
###xml 937 942 <span type="species:ncbi:9606">human</span>
###xml 987 992 <span type="species:ncbi:10090">mouse</span>
###xml 1089 1094 <span type="species:ncbi:10090">mouse</span>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
p53 is a 53 kDa nuclear transcription factor, that recognizes and binds to a specific DNA consensus sequence consisting of two copies of the 10 bp motif 5'-PuPuPuC(A/T)(T/A)GPyPyPy-3', separated by 0 to 13 bp [53]. p53 acts as an activator by binding to this sequence and can also act as a transcriptional repressor of promoters lacking a p53 binding site [54-56]. p53 activates genes involved in DNA repair [30]. Biologically p53 induces G1 arrest and apoptosis following DNA damage [57], and is therefore known as a common tumor suppressor [58]. Many p53 functions are mediated through the activation or repression of a series of genes, and this includes the MMP-2 gene [36]. Mutation of p53 may inactivate the growth regulatory function and cause a loss of tumor-suppressive activity [59]. Mutation at the specific DNA binding domain have been identified in nearly 50% of all human cancers [60]. p53 is present in the preimplantation human embryo [61,62], and is expressed throughout mouse implantation development. The p38 MAPK pathway was found to regulate p53 expression in 2-8 cell mouse embryos [63]. p53-deficient mice are viable and reproductive, however in p53- null (p53(-/-) the placenta is altered [64]. In rodent placenta, a decrease in p53 is part of the transition of trophoblast from a state of proliferation to differentiation in trophoblast [33]. p53 has a short half-live, and is therefore normally present at very low concentrations in cells [30]. However, p53 is detectable in the nucleus and cytoplasm of cytotrophoblasts and syncytiotrophoblasts [30,65,66], and this apparently overexpression of p53 in trophoblasts may be controlling excessive proliferation in normal placentation [67]. It appears that most p53 protein forms complexes in the cytoplasm and tetramers in the nuclei in cytotrophoblasts, suggested to stabilize p53 and hereby prolong the half-life [30,31]. p53 is correlated with enhanced apoptosis in trophoblast [68], and can be induced by hypoxia [69]. Increased p53 and apoptosis was found in different pregnancy complications, such as preeclampsia [69,70], fetal growth restriction [68] and Gestational Trophoblastic diseases (GTDs) [71]. In invasive hydatidiform moles, characterized by abnormal growth of chorionic tissues with various degrees of local invasion and metastasis, MMP-2 and mutant p53, but not wild type p53 (wtp53), were increased, as compared to normal placenta, and may be involved in this pathology [72]. However, since mutant p53 may still perform normal suppressive activity, depending on the localization of the mutation, and since other reports found wtp53 to be elevated in hydatidiform moles [73-75], the role of wtp53 in this pathology is not clear. A recent article described that exogenous p53, but not endogenous p53, decrease MMP-9 in cytotrophoblasts [76]. In their report, in contrast to our results, p53 inhibition had no effect on either MMP-2 or MMP-9, and the authors suggested that p53 is inactivated in trophoblasts, maybe through formation of high molecular weight complexes. These controversial results regarding MMP-2 may result from differences in experimental design, including the use of JAR cells as a model as well as primary trophoblast of different gestational ages (early versus late 1st trimester trophoblast).
###end p 73
###begin p 74
The examined transcription factors in this study are involved in transactivation and transrepression of many genes, thus the EMSA does not allow us to conclude, that MMP-2 is one of them. However, the studies using transfection of p53 and Ets-2 antisense in JAR demonstrate that at least p53 is involved in Forskolin-induced MMP-2 expression, while Ets-2 may effect post-transcriptional regulation. Our results suggest that MMP-2 regulation in trophoblast is mediated by several transcription factors, including p53 and Ets-2, however since MMP-2 transcription, secretion and trophoblast invasion were not completely diminished, other transcription factors must be involved. This may include C/EBP-epsilon, C/EBPlambda and AP-2alpha, which should be subject to further study.
###end p 74
###begin title 75
Conclusion
###end title 75
###begin p 76
MMP-2 regulation by PKA is mediated through several binding sites and transcription factors including Ets-2, p53, C/EBPepsilon, C/EBPlambda and AP-2alpha. Ets-2 and p53 mediate PKA- induced trophoblast invasiveness through regulation of MMP-2 expression and activity.
###end p 76
###begin title 77
Competing interests
###end title 77
###begin p 78
The authors declare that they have no competing interests.
###end p 78
###begin title 79
Authors' contributions
###end title 79
###begin p 80
ESR participated in designing the study, carried out the experiments, performed the data analysis and drafted the manuscript. SG participated in conceiving and designing the study, and helped with the data analysis and with drafting the manuscript. ES conceived and design the study, analyzed the results and edited the manuscript. All authors read and approved the final manuscript.
###end p 80
###begin title 81
Acknowledgements
###end title 81
###begin p 82
The study is part of ESR PhD research thesis submitted to the senate of the Technion, Israel Institute of Technology. The generous financial help of the Technion is gratefully acknowledged.
###end p 82
###begin article-title 83
The role of chorionic gonadotropin (CG) in blastocyst implantation
###end article-title 83
###begin article-title 84
Effects of tumour necrosis factor alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human trophoblast function during the implantation process
###end article-title 85
###begin article-title 86
###xml 82 87 <span type="species:ncbi:9606">human</span>
Degradation of extracellular matrix by the trophoblastic cells of first trimester human placentas
###end article-title 86
###begin article-title 87
###xml 36 41 <span type="species:ncbi:9606">human</span>
Importance of metalloproteinases in human trophoblast invasion
###end article-title 87
###begin article-title 88
Molecular mediators of implantation
###end article-title 88
###begin article-title 89
###xml 48 53 <span type="species:ncbi:9606">human</span>
92-kDa type IV collagenase mediates invasion of human cytotrophoblasts
###end article-title 89
###begin article-title 90
###xml 81 86 <span type="species:ncbi:9606">human</span>
Expression and importance of matrix metalloproteinases 2 and 9 (MMP-2 and -9) in human trophoblast invasion
###end article-title 90
###begin article-title 91
###xml 118 123 <span type="species:ncbi:9606">human</span>
Expression of matrix metalloproteinase-2, -9 and -14, tissue inhibitors of metalloproteinse-1, and matrix proteins in human placenta during the first trimester
###end article-title 91
###begin article-title 92
Interest in preeclampsia for researchers in reproduction
###end article-title 92
###begin article-title 93
First trimester origins of fetal growth impairment
###end article-title 93
###begin article-title 94
Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors
###end article-title 94
###begin article-title 95
Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta
###end article-title 95
###begin article-title 96
###xml 41 46 <span type="species:ncbi:9606">human</span>
Cyclic AMP-dependent protein kinases and human trophoblast cell differentiation in vitro
###end article-title 96
###begin article-title 97
Invasion of cytotrophoblastic JEG-3 cells is stimulated by hCG in vitro
###end article-title 97
###begin article-title 98
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human chorionic gonadotropin as a novel angiogenic factor
###end article-title 98
###begin article-title 99
HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor
###end article-title 99
###begin article-title 100
###xml 15 20 <span type="species:ncbi:9606">human</span>
On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation
###end article-title 100
###begin article-title 101
###xml 52 57 <span type="species:ncbi:9606">human</span>
Progesterone inhibits transcriptional activation of human chorionic gonadotropin-alpha through protein kinase A pathway in trophoblast cells
###end article-title 101
###begin article-title 102
AQP1 gene expression is upregulated by arginine vasopressin and cyclic AMP agonists in trophoblast cells
###end article-title 102
###begin article-title 103
###xml 85 90 <span type="species:ncbi:9606">human</span>
Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast
###end article-title 103
###begin article-title 104
###xml 41 46 <span type="species:ncbi:9606">human</span>
Cyclic AMP-dependent protein kinases and human trophoblast cell differentiation in vitro
###end article-title 104
###begin article-title 105
Regulation of matrix metalloproteinase gene expression
###end article-title 105
###begin article-title 106
###xml 60 65 <span type="species:ncbi:9606">human</span>
Identification of noval, functional genetic variants in the human matrix metalloproteinase-2 gene
###end article-title 106
###begin article-title 107
The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells
###end article-title 107
###begin article-title 108
Antibody Reaction Patterns in First Trimester Placenta: Implications for Trophoblast Isolation and Purity Screening
###end article-title 108
###begin article-title 109
Transcription of Cholesterol Side-Chain Cleavage Cytochrome P450 in the Placenta: Activating Protein-2 Assumes the Role of Steroidogenic Factor-1 by Binding to an Overlapping Promoter Element
###end article-title 109
###begin article-title 110
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers
###end article-title 110
###begin article-title 111
Regulation of Trophoblastic Gelatinases by Proto-oncogenes
###end article-title 111
###begin article-title 112
Status of p53 in first-trimester cytotrophoblastic cells
###end article-title 112
###begin article-title 113
Trophoblastic p53 is stabilized by a cis-trans isomerisation necessary for the formation of high molecular weight complexes involving the N-terminus of p53
###end article-title 113
###begin article-title 114
###xml 119 124 <span type="species:ncbi:9606">Human</span>
A central role for Ets-2 in the transcriptional regulation and Cyclic Adenosine 5'-Monophosphate responsiveness of the Human Chorionic Gonadotrophin-beta subunit gene
###end article-title 114
###begin article-title 115
Differentiation of placental trophoblast giant cells requires downregulation of p53 and Rb
###end article-title 115
###begin article-title 116
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Defective trophoblast function in mice with a targeted mutation of Ets2
###end article-title 116
###begin article-title 117
###xml 54 59 <span type="species:ncbi:9606">human</span>
Positive and negative transcriptional elements of the human type IV collagenase gene
###end article-title 117
###begin article-title 118
###xml 41 46 <span type="species:ncbi:9606">human</span>
Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter
###end article-title 118
###begin article-title 119
###xml 120 125 <span type="species:ncbi:9606">human</span>
Cyclosporin A increases expression of matrix metalloproteinase 9 and 2 and invasiveness in vitro of the first-trimester human trophoblast cells via the mitogen-activated protein kinase pathway
###end article-title 119
###begin article-title 120
###xml 43 48 <span type="species:ncbi:9606">human</span>
Focal adhesion kinase is a key mediator of human trophoblast development
###end article-title 120
###begin article-title 121
###xml 91 96 <span type="species:ncbi:9606">human</span>
Difference in Progesterone receptor isoforms ratio, between early and late first trimester human trophoblast, is associated with differential cell invasion and matrix metalloproteinase2 (MMP2) expression
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human chorionic gonadotrophin stimulates trophoblast invasion through ERK and AKT signaling
###end article-title 122
###begin article-title 123
Molecular biology of the Ets family of transcription factors
###end article-title 123
###begin article-title 124
Signal transduction and the Ets family of transcription factors
###end article-title 124
###begin article-title 125
Ras/Mitogen- activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment
###end article-title 125
###begin article-title 126
Ets transcription factors: nuclear effectors of the Ras-Map-kinase signaling pathway
###end article-title 126
###begin article-title 127
ETS proteins and MMPs: partners in invasion and metastasis
###end article-title 127
###begin article-title 128
Ets factors and regulation of the extracellular matrix
###end article-title 128
###begin article-title 129
###xml 100 105 <span type="species:ncbi:9606">human</span>
Coordinate regulation of basal and Cyclic 5'-Adenosine Monophosphate (cAMP)-activated expression of human chorionic gonadotrophin-alpha by Ets-2 and cAMP-responsive element binding protein
###end article-title 129
###begin article-title 130
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Identification of a placental specific enhancer in the rat placental lactogen II gene that contains binding sites for members of the Ets and AP1 (activator protein1) families of transcription factors
###end article-title 130
###begin article-title 131
Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways
###end article-title 131
###begin article-title 132
Transcriptional activation of the decidual/trophoblast prolactin related protein gene
###end article-title 132
###begin article-title 133
###xml 52 57 <span type="species:ncbi:9606">human</span>
Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/jun complex
###end article-title 133
###begin article-title 134
p53 Mediates Epidermal Growth Factor (EGF) Induction of MMP-2 Transcription and Trophoblast Invasion
###end article-title 134
###begin article-title 135
Definition of a consensus binding site for p53
###end article-title 135
###begin article-title 136
###xml 66 71 <span type="species:ncbi:9606">human</span>
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
###end article-title 136
###begin article-title 137
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Transcriptional activation of the human epidermal growth factor receptor promoter by human p53
###end article-title 137
###begin article-title 138
The tumor suppressor p53
###end article-title 138
###begin article-title 139
P53, cell cycle control and apoptosis: implications for cancer
###end article-title 139
###begin article-title 140
p53: puzzle and paradigm
###end article-title 140
###begin article-title 141
The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
###end article-title 141
###begin article-title 142
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis
###end article-title 142
###begin article-title 143
###xml 91 96 <span type="species:ncbi:9606">human</span>
Expression of genes regulating chromosome segregation, the cell cycle and apoptosis during human preimplantation development
###end article-title 143
###begin article-title 144
###xml 69 75 <span type="species:ncbi:10090">murine</span>
Expression and regulation of genes associated with cell death during murine preimplantation embryo development
###end article-title 144
###begin article-title 145
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
PP2Cdelta (Ppm1d, WIP1), an endogenous inhibitor of p38 MAPK, is regulated along with Trp53 and Cdkn2a following p38 MAPK inhibition during mouse preimplantation development
###end article-title 145
###begin article-title 146
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Increase of the trophoblast giant cells with prolactin-releasing peptide (PrRP) receptor expression in p53-null mice
###end article-title 146
###begin article-title 147
###xml 47 52 <span type="species:ncbi:9606">human</span>
Immunohistochemical evidence of p53 protein in human placenta and choriocarcinoma cell lines
###end article-title 147
###begin article-title 148
Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester
###end article-title 148
###begin article-title 149
###xml 48 53 <span type="species:ncbi:9606">human</span>
Expression of the p53 tumour suppressor gene in human placenta: an immunohistochemical study
###end article-title 149
###begin article-title 150
Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression
###end article-title 150
###begin article-title 151
###xml 80 85 <span type="species:ncbi:9606">human</span>
Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast
###end article-title 151
###begin article-title 152
Gabor Than Award Lecture (2006): pre-eclampsia and villous trophoblast turnover: perspectives and possibilities
###end article-title 152
###begin article-title 153
Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease
###end article-title 153
###begin article-title 154
Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta
###end article-title 154
###begin article-title 155
###xml 83 88 <span type="species:ncbi:9606">human</span>
Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas
###end article-title 155
###begin article-title 156
p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma
###end article-title 156
###begin article-title 157
Expression of the p53 gene and apoptosis in gestational trophoblastic disease
###end article-title 157
###begin article-title 158
Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells
###end article-title 158

